Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
T. C. Owyong, R. O'Shea, M. Lee, J. M. White, P. S. Donnelly, E. Hinde, W. W. H. Wong, Y. Hong
This paper introduces a fluorescence-based method to quantify and map biomolecular polarity in vitro and in cells, showing that polarity varies with phase separation types and stress conditions.
bioRxiv · Feb 7, 2023 · PreprintBiochemistry
A. E. Ward, D. Sokovikova, N. Waxham, F. A. Heberle, I. Levental, K. R. Levental, V. Kiessling, J. M. White, L. K. Tamm
This study shows Serinc5 restricts HIV infection by altering viral membrane lipid order and heterogeneity, reducing fusion pore formation and infectivity.
bioRxiv · Aug 25, 2022Biophysics
A. Ianevski, R. Yao, R. M. Simonsen, V. Myhre, E. Ravlo, G. D. Kaynova, E. Zusinaite, J. M. White, Q. Pan, S. J. Polyak, V. Oksenych, M. P. Windisch, E. Lastauskiene, A. Vitkauskiene, A. Matukevicius, , D. E. Kainov
The paper develops scoring systems to predict novel broad-spectrum antivirals and combinations, aiming to improve preparedness for future viral outbreaks.
bioRxiv · Jan 15, 2022 · PreprintMicrobiology
R. H. Shoemaker, R. A. Panettieri, S. K. Libutti, H. S. Hochster, N. R. Watts, P. T. Wingfield, P. M. Starkl, L. Pimenov, R. Gawish, A. Hladik, S. Knapp, D. Boring, J. M. White, Q. Lawrence, J. Boone, , G. Wirnsberger
This paper reports preclinical development and evaluation of aerosolized soluble recombinant human ACE2 (APN01) as a COVID-19 intervention.
bioRxiv · Sep 14, 2021 · PreprintPharmacology & Toxicology
W. E. Diehl, M. H. Guney, P. P. Kyawe, J. M. White, M. Pizzato, J. Luban
This study investigates how retroviral glycoproteins and cores influence SERINC5 antiviral activity, finding that sensitivity depends on both factors.
bioRxiv · Sep 24, 2019Microbiology